Says ITN well-positioned for continued success
Immune Tolerance Network (ITN) director and founder, Jeffrey A. Bluestone has accepted the position of Executive Vice Chancellor and Provost at the University of California, San Francisco, pending approval by the UC Regents.
Details of his new appointment may be found on the UCSF website .
As he embarks upon his latest challenge at UCSF, Bluestone will step down as Director of the ITN.
From its inception a decade ago, Bluestone has led the ITN with extraordinary dedication. His vision of an open, inclusive research network that reflects the research communities needs and thrives upon innovation has led the ITN to many successes. He is credited with overseeing the rapid growth and evolution of the ITN into a model organization for integrated clinical research, in which mechanism research is conducted side-by-side with clinical investigation.
Daniel Rotrosen, Director of the Division of Allergy, Immunology and Transplantation at the National Institute of Allergy and Infectious Diseases, the ITN's sponsoring organization, reflected on Bluestone's leadership of the ITN.
"Like many of you, I've been touched by his passion, commitment and ability to bring out the best in others. I can count a great many examples of individual and collective accomplishments that would not have been if not for Jeff's influence."
As of yet, no succession plans have been announced, although NIAID leadership has expressed its continued full support of the ITN moving forward.
"As a result of Jeff's leadership, the ITN is well positioned to continue on its successful course. We at NIAID will work with Jeff, the UCSF grants and contracts office and ITN staff and investigators to ensure a smooth transition to new leadership," said Rotrosen.